China conditionally approves one-shot recombinant COVID-19 vaccine

BEIJING, China, Feb 28 – The Chinese National Medical Products Administration granted conditional market approval to a recombinant novel coronavirus vaccine that requires only one shot. Developed by a research team led by Chen Wei, an academician at the Chinese Academy of Engineering and a researcher at the Institute of Military Medicine under the Academy […]...

read more...

Published By: capitalfm - Sunday, 28 February